Health Canada
Symbol of the Government of Canada
About Health Canada

Access to Information Requests Completed - May 2013

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

AER
Adverse Reaction Report (Adverse Event)
DIN
Drug Identification Number
 
 
For the month of May 2013
Request # Summary of Requests Status of Completed Request Number of Pages Disclosed
A-2010-00113 All documents pertaining to any trade or consumer complaint filed against the following company: Flora Manufacturing & Distributing Ltd; specifically with respect to their sale, marketing, or advertising of foods or drug products, including natural health products. Disclosed in part 530
A-2012-00965 All written communication, emails, data and test results passing between Dow AgroSciences Canada Inc. and the Pest Management Regulatory Agency regarding the 2011 label amendment for the florasulam component of PrePass whereby the crop rotation restrictions were changed. Disclosed in part 338
A-2012-01037 All documents used by Health Canada officers to obtain the conclusion relative to Complaint 64164. Complaint filed on May 3, 2011 and conclusion date of November 1, 2011. Disclosed in part 96
A-2012-01203 All correspondence concerning Visalus Sciences or one of its representatives. (Jan 1, 2009 to Nov 11, 2012). Disclosed in part 694
A-2012-01425 A summary of third party requests (members of the public or organizations) made to the Minister of Health requesting the cancellation of pesticide registrations and resulting actions". (Jan 1, 2005 to Jan 3, 2013). Disclosed in part 454
A-2012-01427 2012 briefing notes, reports that lead to changing the supply systems of medical marihuana, including attendant problems with the current regulations. Disclosed in part 32
A-2012-01469 Documents December 16, 2012 announcement by minister Aglukkaq on proposed new marihuana for medical purposes regulation. Disclosed in part 355
A-2012-01484 List or summary of training courses taken by all Department employees, including supervisory staff, with details for each course, such as the cost, course title, name of the supplier and number of participants. (Jan 1, 2012 to Dec 31, 2012). Disclosed in part 339
A-2012-01496 All documents to brief Minister Leona Aglukkaq and/or Acting/Assistant Deputy Minister Kathy Langlois ahead of the January 11, 2013 meeting with Prime Minister Stephen Harper, Assembly of First Nations Chief Shawn Atleo and others. Disclosed in part 322
A-2012-01497 Contract/contribution agreement between Health Canada and Sioux Lookout First Nation Health Authority for the procurement of the new Hostel, completed in early 2011. All disclosed 95
A-2012-01518 AERs for the product BIAXIN. Report numbers: 000430542, 000434418, 000437259, 000443705 and 000451652. Disclosed in part 11
A-2012-01519 All e-mails sent or received by all staff within the office of the Minister and the Deputy Minister related to the National Aboriginal Health Organization (NAHO). (Jan 1, 2011 to Jan 28, 2013). Disclosed in part 104
A-2012-01524 All email correspondence to and/or from Mr. Patrick Fitch, Senior Labour Relations Advisor, Human Resources Services Directorate, Corporate Services Branch, mentioning the Ancien Group. (Jan 1, 2009 to Jan 17, 2013). Disclosed in part 29
A-2012-01525 All email correspondence to and/or from Mr. Patrick Fitch, Senior Labour Relations Advisor, Corporate Labour Relations, Human Resources Services Directorate, Corporate Services Branch, mentioning Joelle Fougere. (Jan 1, 2009 to Jan 17, 2013). Disclosed in part 29
A-2012-01541 All documents produced regarding 'energy shots' and/or 'energy drinks' produced during the week of February 8, 2013. Disclosed in part 82
A-2012-01542 Information regarding the product Keflex, DIN 00244392 and 00403628 by Pendopharm, Division of/de Pharmascience Inc. Disclosed in part 66
A-2012-01552 All correspondence from Ryan Johnstone, with respect to or making mention of the RedPath Mobile Addiction Treatment Program, Mobile Addiction Treatment, the RedPath Programs and training and/or Whitepath Inc. (Jan 1, 2012 to Jan 31,2013). Disclosed in part 65
A-2012-01569 All documents pertaining to any requests and/or applications for grants, honoraria, scholarships, or any other forms of funding made by Buffalo Point First Nation to Health Canada. (Oct 1, 1997 to Feb 15, 2013). Disclosed in part 221
A-2012-01570 All documents pertaining to any funding provided by Health Canada to Buffalo Point First Nation. (Feb, 16, 2008 to Feb, 15, 2013). Disclosed in part 1,380
A-2012-01584 All funding agreements/amendments pertaining to the Woodstock First Nation, New Brunswick. (Jan 1, 2005 to Feb, 19, 2013). Disclosed in part 914
A-2012-01604 AER for the product Yasmin. Report number: 000461530. Disclosed in part 2
A-2012-01618 AERs for the product Cymbalta. Report numbers: 000397830, 000381114, 000383893, 000386303, 000386480, 000400084, 000406744, 000414575, 000415548, 000416891 and 000417149. Disclosed in part 17
A-2012-01623 AERs for the product Cialis. Report numbers: 000398252, 000398551, 000404897, 000410975, 000415114, 000444890, 000444768, 000445407 and 000462209. Disclosed in part 31
A-2012-01631 AERs for the product Strattera. Report numbers: 000436065, 000442056, 000455392, 000461887, 000461909, 000461929 and 000462862. Disclosed in part 13
A-2012-01647 Information relating to the business activities of Enviroway Detergent Manufacturing Inc. All disclosed 13
A-2012-01685 All documents and analysis comparing and contrasting the Canadian, United States and other national standards systems, including relative competitive benefits and risks of each system. (Nov 1, 2011 to Feb 26, 2013). Disclosed in part 95
A-2012-01687 All records supporting the Standards Council of Canada's assertion in its Communique dated July 20, 2012 that a growing number of Canadians are participating directly in standards development activities outside of Canada. (Nov 1, 2011 to Feb 26, 2013). Disclosed in part 33
A-2012-01739 Documentation relating to Standing Offers Arrangements for French language training services, which could be used, or were used by Health Canada. (Mar 1, 2012 to Mar 15, 2013. Disclosed in part 299
A-2012-01744 All briefing material to the Deputy Minister regarding Information Technology (IT) Security, information management security, and cyber security. (Jan 1, 2012 to Mar 19, 2013). Disclosed in part 64
A-2012-01748 List of all contributions made by Health Canada related to Nutrition North Canada. (Apr 1, 2010 to Mar 15, 2013). All disclosed 2
A-2012-01766 Comments received in response to the October 25, 2012 information and notification document on Health Canada's proposal to enable the use of Dimethyl Dicarbonate as a preservative in wine and in unstandardized water based non-alcoholic beverages. All disclosed 4
A-2013-00001 Funding agreements between Health Canada and the Mental Health Commission of Canada. All disclosed 119
A-2013-00005 All call-ups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of March 2013. Disclosed in part 33
A-2013-00009 Documents indicating the number of medical marijuana grow licenses that were issued in 2012 of the following Municipalities/Villages and Districts: Resort Municipality of Whistler, Village of Pemberton, District of Squamish and Squamish Lillooet Regional District. All disclosed 1
A-2013-00012 List of authorized growers for Marihuana. All disclosed 1
A-2013-00018 A listing of the Access to Information requests submitted to Health Canada. (Mar 1, 2013 to Mar 31, 2013). Disclosed in part 9
A-2013-00021 All applications submitted for an exemption to the Controlled Drugs and Substances Act for operation of a supervised injection site in Toronto or Ottawa. (Jan 1, 2005 to Apr 11, 2013). No records exist 0
A-2013-00024 All documents showing the number of calls made to the emergency number of Health Canada's Health Products and Food Branch Inspectorate to report counterfeit bogus products, including, in particular, Botox and Juvederm fillers. (Mar 12, 2011 to Mar 11, 2013). No records exist 0
A-2013-00025 All correspondence between the Department of Health and Royal Canadian Mounted Police (RCMP) officials making reference to counterfeit products, such as  Botox and Juvederm fillers. (Nov 1, 2012 to Apr 8, 2013). No records exist 0
A-2013-00027 Documents regarding a detailed budget of the Marihuana Medical Access Program from the beginning of the program's existence until fiscal year 2012-2013. All disclosed 2
A-2013-00033 Data showing the number of bogus (imitation) Botox products sold to Canadians and for which you have received complaints. (Jan 1, 2006 to Apr 15, 2013). No records exist 0
A-2013-00034 Complete copy of the most recent Health Canada reports on adverse reaction statements involving bogus or imitation Botox cosmetic products. (Jan 1, 2013 to Apr 15, 2013). No records exist 0
A-2013-00039 List of all contracts between Health Canada and Dr. Krewski. (Jan 1, 2007 to Apr 17, 2013). All disclosed 3
A-2013-00042 All health risk assessments completed in fiscal year 2012-13 by Health Canada in response to complaints regarding direct-to-consumer advertising of prescription and schedule D drug advertising. No records exist 0
A-2013-00043 Documents relating to the Advertising Advisory Opinion in fiscal year 2012-13. No records exist 0
A-2013-00068 A copy of a document titled Reporting on National Nuclear Emergency Preparedness prepared by International Safety Research. (Nov 7, 2012 to Apr 19, 2013). No records exist 0
A-2013-00072 AER for the product ACTOS. Report number: 000465276. Disclosed in part 2
A-2013-00073 AERs for the product Dexilant. Report numbers: 000453729, 000456200, 000461900, 000462813, 000467390, 000468708, 000476086, 000482366, 000484822 and 000460842. Disclosed in part 12
A-2013-00074 AER for the product Uloric. Report number: 000483490. Disclosed in part 3
A-2013-00077 AERs for the product Alvesco. Report numbers: 000450147, 000460718, 000471611 and 000487517. Disclosed in part 4
A-2013-00078 AER for the product Omnaris. Report number: 000470697. Disclosed in part 1
A-2013-00079 AERs for the product Daxas. Report numbers: 000448191 and 000458250. Disclosed in part 2
A-2013-00081 AERs for the product Adalat XL. Report numbers: 000475306 and 000476089. Disclosed in part 2
A-2013-00082 AERs for the product Avelox. Report numbers: 000475292, 000475558, 000476857 and 000476909. Disclosed in part 5
A-2013-00083 AERs for the product Gadovist. Report numbers: 000474371, 000477639, 000478022, 000478417 and 000480344. Disclosed in part 5
A-2013-00084 AERs for the product Magnevist. Report numbers: 000475719, 000476995 and 000480077. Disclosed in part 5
A-2013-00085 AERs for the product Mirena. Report numbers: 000478563, 000479979 and 000481057. Disclosed in part 3
A-2013-00086 AERs for the product Xarelto. Report numbers: 000474814 and 000479739. Disclosed in part 2
A-2013-00087 AERs for the product Yaz. Report numbers: 000474740, 000478894 and 000481466. Disclosed in part 3
A-2013-00095 AER for the product Pradax. Disclosed in part 1
A-2013-00103 Labelling standard for dental and oral care products for professional use-fluoride-varnish. No records exist 0
A-2013-00106 Documents regarding dental services offered to Nunavut's Inuit population through the Non-Insured Health Benefits program between 1999 and 2012 for:
- Extractions;
- Endodontic treatment (root canals).
All disclosed 1
A-2013-00107 Documents regarding dental services offered to Nunavut's Inuit population through the Non-Insured Health Benefits program between 1999 and 2012 for:
- Average annual number of claims per claimant by age group;
- Average annual cost per claimant by age group;
- Total costs per year by age group;
- Claimant rate by age group for preventative services.
All disclosed 11
A-2013-00108 Documents regarding dental services offered to Nunavut's Inuit population through the Non-Insured Health Benefits program between 1999 and 2012 for:
- Orthodontic approval rates;
- Appeals by class (first, second, and third) and by procedure (endodontic, orthodontic, restorative, prosthodontics).
All disclosed 2
A-2013-00109 Documents regarding dental services offered to Nunavut's Inuit population through the Non-Insured Health Benefits program between 1999 and 2012 for:
- Nitrous oxide approval rates;
- Number of children under the age of 12 who submitted eight or more claims for dental care benefits on the same day.
All disclosed 2
A-2013-00113 AERs for the product Celexa. Report numbers: 000478584 and 000485313. Disclosed in part 6
A-2013-00114 AER for the product Sabril. Report number: 000470377. Disclosed in part 1
A-2013-00117 The report created in August 1989 regarding the PCB (polychlorinated biphenyls) Study for Big Trout Lake / Weagamow Lake. All disclosed 36
A-2013-00118 Copy of Kitchenuhmaykoosib Sioux Lookout Zone Environmental Contaminants Health Study created by Health Canada in 1998. All disclosed 55
A-2013-00119 Documents regarding the nutrient intake of adults aged 15-65 for Big Trout Lake / Weagamow Lake. Disclosed in part 43
A-2013-00120 The Sioux Lookout Zone Environmental Contaminants Study - Kitchenuhmaykoosib created by Health Canada's First Nations and Inuit Health Branch in 2000. All disclosed 23
A-2013-00124 All call-ups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of April 2013. Disclosed in part 97
A-2013-00125 Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during April 2013. All disclosed 3
A-2013-00128 AER. Report number: 000468298. Disclosed in part 1
A-2013-00129 AER. Report number: 000470244. Disclosed in part 1
A-2013-00130 AER. Report number: 000473631. Disclosed in part 1
A-2013-00131 AER. Report number: 000484939. Disclosed in part 1
A-2013-00132 AER. Report number: 000473945. Disclosed in part 1
A-2013-00136 AER. Report number: 000476035. Disclosed in part 1
A-2013-00137 AER. Report number: 000476083. Disclosed in part 1
A-2013-00143 AER. Report number: 000484303. Disclosed in part 1
A-2013-00144 AER. Report number: 000487347. Disclosed in part 1
A-2013-00174 Aggregated (non-identifying) data regarding the following information required to be reported by pharmacies to Health Canada pursuant to a Health Canada letter dated November 26, 2012: Sales reports of all controlled release formulations of oxycodone products and reports of unusual orders involving controlled release formulations of Oxycodone products. No records exist 0
A-2013-00175 All documents relating to the construction, maintenance, abatement, decommissioning or operation of the TransCanada pipeline. No records exist 0
A-2013-00176 Data or statistics about asbestos or silica exposure or rates of mesothelioma in relation to TransCanada pipeline workers. No records exist 0
A-2013-00177 Regulatory approvals related to the TransCanada pipeline, including but not limited to regulatory documents related to air quality or the use of silica or asbestos. No records exist 0
A-2013-00178 All Industrial hygiene reports, dust reports, air sampling, safety complaints or inspections related to respiratory or air quality conditions or the use of silica or asbestos, in relation to the TransCanada pipeline. No records exist 0
A-2013-00179 All correspondence related to Anova Food or Clearsmoke Technologies. (Jan 1, 2011 to Apr 29, 2013). No records exist 0
A-2013-00182 All letters of advisory opinion issued with respect to enzymes or enzyme preparations by Health Canada. (Apr 1, 2004 to Mar 31, 2007). No records exist 0
A-2013-00185 All letters of advisory opinion issued with respect to enzymes or enzyme preparations by Health Canada. (Apr 1, 2000 to Mar 31, 2004). No records exist 0
A-2013-00248 Information on Medtronic CoreValve interim analysis (30 days) from the ongoing United States Investigational Device Exemption study. No records exist 0